Navigation Links
International liver cancer congress provides possible solutions to reduce significant burden
Date:6/25/2010

Geneva, Switzerland, Friday, 25 June 2010: Today, world renowned experts have assembled in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future management of hepatocellular carcinoma (HCC) the third most common cause of cancer-related death globally, and a leading cause of death among patients with liver cirrhosis.

"This HCC conference is a significant milestone in the field of HCC research. We are encouraged by the range of topics and eminent researchers in attendance, bringing new understanding and celebrating new research opportunities from across the world that will help address the current challenges we face as clinicians. This ultimately will help drive our ultimate goal of reducing the suffering caused by this devastating and debilitating disease," commented Professor Josep M Llovet, chair of the HCC special conference and Professor of Research, Liver Unit, Hospital Clnic, Barcelona, Spain and Professor of Medicine, Director, Mount Sinai Liver Cancer Research Program, Mount Sinai School of Medicine, New York.

At the two-day conference, entitled: Hepatocellular Carcinoma from genomics to treatment, organised by the European Association for the Study of the Liver (EASL), experts will address a range of key topics, including: the genetic make-up of HCC, the molecular signatures and biomarkers and other advancements to determine diagnosis and prognosis of HCC, and potential disease targets to develop new treatment strategies. Specifically, several novel molecular targeted therapies are currently being tested in advanced stages of clinical research, and their results expected by 2011-14 might improve the standard of care of patients suffering this neoplasm.

HCC is a cancer originating in liver cells and is one of the most common types of tumour. Worldwide, HCC accounts for approximately 5.4% of all cancers3 and causes 610,000 deaths per year. It is the fifth most common cause of cancer in men and the eighth most common cause in women. HCC is the most common cancer in Sub-Saharan Africa and Southeast Asia mainly due to the high rates of HCV and HBV infection. In western countries, alcoholism and viral hepatitis are the leading causes of cirrhosis and subsequent HCC.

The HCC conference is supported by leading professional organisations across the world, including the American Association for the Study of Liver Diseases (AASLD), the Asian Pacific Association for Study of the Liver (APASL) and the Latin-American for the Study of the Liver (ALEH).

"EASL is dedicated to promoting research and education in the field of hepatology to improve the treatment of liver disease throughout the world. In bringing experts together at this first-ever medical conference on HCC we aim to promote the latest evidence base and best practise to address this significant global killer disease," added Professor Heiner Wedemeyer, EASL Secretary General.

In line with the importance of the meeting, EASL would like to inform its members and the conference delegates that the European Commission Seventh Framework Programme (FP7-Health 2010) has funded the HEPTROMIC project, a 3-year translational research initiative on liver cancer. This network, aimed at solving molecular and technological challenges, constitutes the first European research project specifically focused on genomics in HCC funded by the European Union. With the final negotiations with the European Commission well underway, HEPTROMIC is currently gearing up to become a decisive modern cooperative and multidisciplinary effort in the fight against this cancer. Led from the Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS) - Hospital Clnic of Barcelona (Spain), this initiative combines the knowhow of six leading research groups in Europe and the USA and two companies, to ensure the translation of research results into new prognostic tests and devices.


'/>"/>

Contact: Isabelle Scali
media.easl2010@cohnwolfe.com
44-771-743-5103
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
2. Global Aids Alliance Celebrates the Introduction of the International Violence Against Women Act, Urges Swift Passage
3. International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine
4. Ganeden Biotech and Pathway International Announce Exclusive Distribution Partnership
5. Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
6. Rapport International Announces Partnership with SDL
7. MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief
8. Sanford Heart Hospital Physicians Again Recognized Internationally for Innovative Techniques
9. Chances For Children Founder Craig Juntunen Urges International Adoption as Part of the Solution in Aftermath of Haiti Earthquake
10. International Breast Milk Project Delivers Donor Breast Milk to Orphaned and Sick Babies in Haiti
11. AMD Alliance International Announces $10,000 Video Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Santa Rosa, CA (PRWEB) , ... January 21, ... ... announce the opening of its new medical office in Petaluma, located at 167 ... full-service casting room, access to SRO sports medicine and rehabilitation services ...
(Date:1/20/2017)... Abilene, Texas (PRWEB) , ... January 20, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... back the bible in homes across the world. Yisrayl says this generation is a time ... better is to turn to the Bible. , Yisrayl says he does not want to ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the ... an educator interacting with countless women who had little knowledge of the female characters ...
(Date:1/20/2017)... ... ... “Christmas in Suffolk”: a story of love, secrets, and mystery. “Christmas in Suffolk” ... she works in a daycare and looks for inspiration in the local coffee shop ... Sara Seymour’s new book is an adventure of love and secrets. , ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)...  Ethicon Endo-Surgery, Inc. announced today that ... a privately held medical device company that ... in operating rooms worldwide. The acquisition brings ... devices with Megadyne,s innovative portfolio of electrosurgical ... Ethicon,s goal to deliver the most comprehensive ...
(Date:1/20/2017)... 2017 Research and Markets has announced ... Opportunities, and Future" report to their offering. ... This research service on the ... technologies, and provides a snapshot of the key participants in the ... are provided from 2016 to 2020. The market is expected to ...
(Date:1/20/2017)... 2017 Wells Specialty Pharmacy announces the acquisitions and ... in Winter Park, Florida and Pharm-EZ ... Operations have been consolidated into the 3796 Howell Branch Road ... announce that Chad Tomlinson , former Vice President of ... immediately. Mr. Tomlinson is a Graduate of Florida State University ...
Breaking Medicine Technology: